Efficacy of IL-13 neutralization in a sheep model of experimental asthma.
about
Proinflammatory role for let-7 microRNAS in experimental asthmaPathways activated during human asthma exacerbation as revealed by gene expression patterns in bloodNeutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite.Targeting interleukin-4 in asthma: lost in translation?Cytokine/anti-cytokine therapy - novel treatments for asthma?New drugs targeting Th2 lymphocytes in asthma.Novel medications for asthma: a look at the future.A novel and sensitive ELISA reveals that the soluble form of IL-13R-alpha2 is not expressed in plasma of healthy or asthmatic subjects.Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma.The pharmacological modulation of allergen-induced asthma.Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS)Interleukins and large domestic animals, a bibliometric analysis.Non-Clinical Pharmacokinetics, Prediction of Human Pharmacokinetics and First-in-Human Dose Selection for CNTO 5825, an Anti-Interleukin-13 Monoclonal Antibody.A mechanistic PK/PD model for two anti-IL13 antibodies explains the difference in total IL-13 accumulation observed in clinical studies.Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study.Unexpected Toxicology Findings in Rats Dosed With an Antihuman IL-13 Monoclonal Antibody.Preclinical Safety and Pharmacology of an Anti-Human Interleukin-13 Monoclonal Antibody in Normal Macaques and in Macaques with Allergic Asthma
P2860
Q24604272-F0353C50-5D06-42B6-90E6-E3DF25322AA3Q28742613-F441D34D-1C88-4B28-A514-A6F20696CFD5Q33722148-03BD7AFB-8CE6-4322-A96E-28E16E1D2E82Q34271232-BD752AF1-892C-45A4-9021-86592974EE92Q34903133-8044CC48-FFA3-4988-90AB-085F9DDF3958Q36485165-903F3950-215B-4CC6-AFA1-80DF28880A37Q36821380-27BEB903-9EF2-45B6-AAB1-1B5002C39427Q37221291-61E97034-7202-4D5F-B4EC-3C46B0E9EF96Q37239764-54578013-17B0-4CF6-B14B-B06AC2B54F50Q38055384-E8A88523-99B1-4A92-8E07-16B0E8953088Q38485579-E6A22418-DAF8-410B-A6C0-A48A1C745696Q41096363-54DA7FA8-9763-43F0-B4DA-5A32A308024AQ41433501-FF3C3B86-DB3E-47CB-9742-A9519E93AD36Q41873060-06C26FD3-B9B9-482C-9BEF-70C31D01C63DQ44799322-19362812-DDB8-49B2-A324-F59CC3565FB2Q48102317-3B1691EA-13AC-451B-BBF6-45FAF628A109Q53779331-B65672E4-464E-401F-9268-30DC65444C7F
P2860
Efficacy of IL-13 neutralization in a sheep model of experimental asthma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Efficacy of IL-13 neutralization in a sheep model of experimental asthma.
@en
Efficacy of IL-13 neutralization in a sheep model of experimental asthma.
@nl
type
label
Efficacy of IL-13 neutralization in a sheep model of experimental asthma.
@en
Efficacy of IL-13 neutralization in a sheep model of experimental asthma.
@nl
prefLabel
Efficacy of IL-13 neutralization in a sheep model of experimental asthma.
@en
Efficacy of IL-13 neutralization in a sheep model of experimental asthma.
@nl
P2093
P2860
P356
P1476
Efficacy of IL-13 neutralization in a sheep model of experimental asthma.
@en
P2093
Angela Widom
Anthony B Barry
Ashfaq Ahmed
Bruce A Jacobson
Debra D Donaldson
Kimberly Marquette
Lioudmila Tchistiakova
Marion T Kasaian
Samuel J Goldman
Timothy A Cook
P2860
P304
P356
10.1165/RCMB.2006-0244OC
P577
2006-10-05T00:00:00Z